Oncology Expansion

We need to talk money.

What range is Merck giving?

I hear $135k is average. This is a lot for big Pharma but they have to compete with BMS and Genentech head to head and won't last a second with an underpaid sales force. What is the deal?

Is this real?

 

Other oncology drugs coming down the pike have greater cure rates and are more versatile. BMS is a prime example of that. They play their cards close to their chest, so they won't get Wall Street revved up only to disappoint later.

 

The manager is lazy and a back stabber. Stay away!

 

135k, hahaha. That is AVERAGE oncology pay, for which Merck reps could only wish for. Since we are being recruited from the outside, more more more. Can you imagine being the Merck rep promoting intronA/Sylatron, only to have new hire stepping all over your melanoma contacts. Go to Ipsen, Sandoz, stay away from this group.

 

Just saw announcement that Merck is selling a valuable cancer pipeline drug to Pfizer - does not sound kosher for the Oncology Division

 

Merck KGaA has ZERO relationship to Merck in the US. Different company, different drug, haven't been related for almost a hundred years. Similar in name only. That pfizer announcement has nothing to do with Merck in the US.

 

This is correct. Read the website Fierce Biotech.